TRAW
TRAW
NASDAQ · Pharmaceuticals

Traws Pharma Inc

$0.84
-0.05 (-6.09%)
Financial Highlights (FY 2026)
Revenue
5.05M
Net Income
16.59M
Gross Margin
Profit Margin
328.7%
Rev Growth
+131.1%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 34.9% 34.9% 34.9%
Operating Margin -640.7% 18.7% 18.2% 19.0%
Profit Margin 328.7% 13.2% 16.7% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.05M 4.81M 4.77M 3.83M
Gross Profit 1.68M 1.66M 1.34M
Operating Income -32,333,114 901.1K 867.4K 727.7K
Net Income 16.59M 633.7K 796.1K 510.0K
Gross Margin 34.9% 34.9% 34.9%
Operating Margin -640.7% 18.7% 18.2% 19.0%
Profit Margin 328.7% 13.2% 16.7% 13.3%
Rev Growth +131.1% +22.7% +21.0% +9.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 6.83M 5.75M 5.44M
Total Equity 8.41M 8.92M 7.51M
D/E Ratio 0.81 0.64 0.73
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -32,325,467 1.15M 1.15M 1.01M
Free Cash Flow 870.8K 772.5K 534.0K